Hims & Hers Adds Novo Nordisk GLP-1 Medications Including Wegovy Starting at $149
Hims & Hers has added Novo Nordisk’s FDA-approved GLP-1 medications, including the only weight-loss pill Wegovy, to its platform with prices starting at $149 monthly. Customers can access semaglutide injections and pills across multiple doses and join a weight-loss membership at $39 first month, $149 thereafter.
1. Partnership Details
Hims & Hers has entered a collaboration with Novo Nordisk to offer a broad assortment of FDA-approved GLP-1 medications on its digital health platform, including the only GLP-1 weight-loss pill, Wegovy.
2. Medication Options and Pricing
Eligible customers can access semaglutide injections ranging from 0.25 mg to 2.4 mg and oral doses from 1.5 mg to 25 mg, with prices starting at $149 per month.
3. Weight Loss Membership Program
The newly launched membership includes 24/7 direct provider access, personalized nutrition guidance and peer support, priced at $39 for the first month and $149 per month thereafter.
4. Strategic Impact
This expansion makes Hims & Hers the largest global consumer health platform for affordable GLP-1 access, with treatments designed to help eligible users achieve up to 20% bodyweight reduction.